Ampicillin sulbactam

Revision as of 19:04, 27 September 2011 by WikiBot (talk | contribs) (Protected "Ampicillin/sulbactam": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Ampicillin sulbactam
Combination of
AmpicillinPenicillin antibiotic
SulbactamBeta-lactamase inhibitor
[[{{{component3}}}]]? Class
[[{{{component4}}}]]? Class
[[{{{component5}}}]]? Class
Clinical data
ATC code
Identifiers
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Ampicillin sulbactam

Articles

Most recent articles on Ampicillin sulbactam

Most cited articles on Ampicillin sulbactam

Review articles on Ampicillin sulbactam

Articles on Ampicillin sulbactam in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ampicillin sulbactam

Images of Ampicillin sulbactam

Photos of Ampicillin sulbactam

Podcasts & MP3s on Ampicillin sulbactam

Videos on Ampicillin sulbactam

Evidence Based Medicine

Cochrane Collaboration on Ampicillin sulbactam

Bandolier on Ampicillin sulbactam

TRIP on Ampicillin sulbactam

Clinical Trials

Ongoing Trials on Ampicillin sulbactam at Clinical Trials.gov

Trial results on Ampicillin sulbactam

Clinical Trials on Ampicillin sulbactam at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ampicillin sulbactam

NICE Guidance on Ampicillin sulbactam

NHS PRODIGY Guidance

FDA on Ampicillin sulbactam

CDC on Ampicillin sulbactam

Books

Books on Ampicillin sulbactam

News

Ampicillin sulbactam in the news

Be alerted to news on Ampicillin sulbactam

News trends on Ampicillin sulbactam

Commentary

Blogs on Ampicillin sulbactam

Definitions

Definitions of Ampicillin sulbactam

Patient Resources / Community

Patient resources on Ampicillin sulbactam

Discussion groups on Ampicillin sulbactam

Patient Handouts on Ampicillin sulbactam

Directions to Hospitals Treating Ampicillin sulbactam

Risk calculators and risk factors for Ampicillin sulbactam

Healthcare Provider Resources

Symptoms of Ampicillin sulbactam

Causes & Risk Factors for Ampicillin sulbactam

Diagnostic studies for Ampicillin sulbactam

Treatment of Ampicillin sulbactam

Continuing Medical Education (CME)

CME Programs on Ampicillin sulbactam

International

Ampicillin sulbactam en Espanol

Ampicillin sulbactam en Francais

Business

Ampicillin sulbactam in the Marketplace

Patents on Ampicillin sulbactam

Experimental / Informatics

List of terms related to Ampicillin sulbactam

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Ampicillin/sulbactam is a combination of the common penicillin-derived antibiotic ampicillin and sulbactam, an inhibitor of bacterial beta-lactamase. Two different forms of the drug exist. The first, developed in 1987 and marketed in the United States under the tradename Unasyn, is an intravenous antibiotic. The second, an oral form called sultamicillin, is marketed under the trade name Ampictam outside of the United States. Ampicillin/sulbactam is used to treat infections caused by bacteria resistant to beta-lactam antibiotics. Sulbactam blocks the enzyme which breaks down ampicillin and thereby allows ampicillin to attack and kill the bacteria.

File:Ampicillin-2D-skeletal.png File:Sulbactam.svg File:Sultamicillin schematic.svg
Skeletal formula of ampicillin Skeletal formula of sulbactam Skeletal formula of sultamicillin, highlighting ampicillin in blue and sulbactam in orange

Ampicillin/sulbactam is also used when the cause of an infection is not known (empiric therapy). Intra-abdominal infections, skin infections, pneumonia, and gynecologic infections. It is active against a wide range of bacterial groups, including Staphylococcus aureus, Enterobacteriaceae, and anaerobic bacteria. Importantly, it is not active against Pseudomonas aeruginosa and should not be used alone when infection with this organism is suspected or known.

Template:SIB

Template:WS